Pamorelin LA 3.75mg Powder for Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Triptorelin (3.75mg)
Overview Pamorelin LA 3.75mg Powder for Injection
Triptorelin LA 3.75mg powder for injection is indicated for managing prostate cancer. It's also employed in the treatment of endometriosis (excessive uterine lining growth leading to symptoms such as pain, heavy or irregular menstruation), and central precocious puberty (premature onset of puberty). Administration is via subcutaneous injection by a healthcare professional. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can result in serious adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include flushing, weakness, diaphoresis, lethargy, lower back pain, and impotence. Prolonged use might lead to osteopenia and decreased bone density; calcium and vitamin D supplementation is recommended. Amenorrhea (absence of menstruation) for 7-12 weeks is possible; persistent bleeding during treatment necessitates medical consultation. Disclose any history of alcohol consumption, smoking, or bone fragility prior to commencing treatment. Inform your healthcare provider of all concurrent medications, as interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception is crucial for both partners throughout the treatment period.
Uses of Pamorelin LA 3.75mg Powder for Injection
Male prostate malignancy | Uterine endometriosis | Early-onset puberty
Major Benefits of Pamorelin LA 3.75mg Powder for Injection:
Administering this medication requires a healthcare professional; your doctor or nurse will provide it to you. Self-medication is not advised.
Common Side effects of Pamorelin LA 3.75mg Powder for Injection:
- Weakness
- Increased sweating
- Back pain
- Paresthesia (tingling or pricking sensation)
- Hot flashes
- Erectile dysfunction
How to use Pamorelin LA 3.75mg Powder for Injection:
Administering this medication requires a healthcare professional; please only receive it from your doctor or nurse.
How Pamorelin LA 3.75mg Powder for Injection works:
Pamorelin LA 3.75mg injectable powder lowers sex hormone production, specifically testosterone in men and estrogen in women. Its mechanism involves reducing circulating testosterone in males. Furthermore, it suppresses ovarian hormone synthesis in females, consequently decreasing estrogen levels and impacting menstruation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pamorelin LA 3.75mg Powder for Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administration of Pamorelin LA 3.75mg Powder for Injection is contraindicated during pregnancy. Pregnant individuals should consult their physician; research in animal and human subjects indicates substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Pamorelin LA 3.75mg injectable powder while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Pamorelin LA 3.75mg injectable powder can induce adverse reactions that might impair driving capabilities. These may include dizziness, fatigue, or visual disturbances like blurred vision, potentially affecting the ability to operate a vehicle safely.
KidneyCAUTION
Individuals with impaired kidney function should use Pamorelin LA 3.75mg Powder for Injection cautiously. Dosage modification for Pamorelin LA 3.75mg Powder for Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Pamorelin LA 3.75mg Powder for Injection cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Pamorelin LA 3.75mg Powder for Injection :
Omit a Pamorelin LA 3.75mg injectable powder dose? Seek medical advice immediately.
Facts to Know About Pamorelin LA 3.75mg Powder for Injection
| Label | Value |
|---|---|
| Chemical Category | Protein chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | GnRH agonists and analogs |

